UK extends GM crops debate deadline

Critics say government forced into allowing more time for discussion.

Written byPat Hagan
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

LONDON — A UK government decision to extend the period for a public debate on GM crops has received a warm welcome.

Environment secretary Margaret Beckett confirmed this week she is pushing back the deadline for the debate to the end of September from the end of June. She also announced an increase in funding for the exercise to £500,000, up from £250,000 originally. It follows an unprecedented attack on the government's commitment to the debate back in November by a group of eleven scientific advisers, charged with helping to set up the consultation exercise.

They slammed the £250,000 funding as "derisory" and accused ministers setting an unrealistic cut-off date so that they "accept commercialization".

Confirmation of the extended deadline came in a letter from Beckett to the advisory group chairman Professor Malcolm Grant. Before Christmas, Grant had written to the environment secretary warning he had not been given enough ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo
Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo

Products

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella